Loading data for VTGN — first visit, this takes a few seconds.
Vistagen Therapeutics Inc... (VTGN)
NasdaqCM: VTGN
· Real-Time Price · USD
0.25
-0.01 (-3.85%)
At close: Aug 28, 2026, 3:59 PM
0.25
-1.15%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Vistagen Therapeutics Inc. (VTGN) Stock Price, Analysis & Data
-3.85% (1D)
| Bid | 0.18 |
| Market Cap | 11.22M |
| Revenue (ttm) | 2.5M |
| Net Income (ttm) | -67.62M |
| 0.38 | |
| -1.66 | |
| n/a | |
| -0.16 | |
| P/B (ttm) | 0.46 |
| P/S (ttm) | 4.49 |
| Earnings Date | Nov 12, 2026 |
| Ask | 0.33 |
| Volume | 448,950 |
| Avg. Volume (20D) | 4,055,420 |
| Open | 0.26 |
| Previous Close | 0.26 |
| Day's Range | 0.25 - 0.26 |
| 52-Week Range | 0.20 - 5.14 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About VTGN
Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline includes Fasedienol, an investigational pherine nasal spray that is in Phase III clinical trial for the treatment of anxiety in adults with social anxiety disorder; and Itruvone, an odorless synthetic investigational neuroactive pherin...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 21, 2011
Employees 41
Stock Exchange NasdaqCM
Ticker Symbol VTGN
Website https://www.vistagen.com
Financial Performance
In 2026, Vistagen Therapeutics's revenue was 1.27M, an increase of 161.11% compared to the previous year's 486K. Earnings were -69.69M, an increase of 35.53%.
Financial StatementsEarnings Surprise
Vistagen Therapeutics has released their quarterly earnings on Aug 14, 2026:
- Revenue of $465K misses estimates by $0, with -3200.00% YoY decline.
- EPS of -0.3 exceeds estimates by 0.06, with 36.17% YoY growth.
Vistagen Therapeutics Inc. is scheduled to release its earnings on Nov 12, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2